Ignite Creation Date:
2025-12-24 @ 5:48 PM
Ignite Modification Date:
2025-12-25 @ 3:15 PM
Study NCT ID:
NCT00058968
Status:
COMPLETED
Last Update Posted:
2007-05-17
First Post:
2003-04-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study for the Treatment of Painful Diabetic Neuropathy
Sponsor:
Eli Lilly and Company
Organization:
Study Overview
Official Title:
Duloxetine Versus Placebo in the Treatment of Patients With Painful Diabetic Neuropathy
Status:
COMPLETED
Status Verified Date:
2007-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine if duloxetine can help patients with painful diabetic neuropathy.
Detailed Description:
The protocol will assess the efficacy and safety of duloxetine. It will also look at how duloxetine affects quality of life.
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| F1J-MC-HMAV | None | None | View |